Pfizer found a way to boost its ailing stock — agree with Trump on drug pricing
4 weeks ago
52
Pfizer’s stock surged after CEO Albert Bourla announces an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty.